Protagonist Therapeutics Inc (PTGX)

32.80 +0.53  +1.64% NASDAQ Dec 6, 13:07 USD
View Full Chart
Price Chart
View All PTGX News

News

View All Events

Events

Date Type Description
03/10/2022 16:30 EST Earnings Calls Q4 2021 Earnings Call
03/10/2022 Earnings Results Q4 2021 Earnings Results
11/03/2021 Earnings Results Q3 2021 Earnings Results
08/04/2021 Earnings Results Q2 2021 Earnings Results
05/27/2021 13:00 EST AGM 2020 Annual General Meeting
05/04/2021 Earnings Results Q1 2021 Earnings Results
03/10/2021 16:30 EST Earnings Calls Q4 2020 Earnings Call
03/10/2021 Earnings Results Q4 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidate to address medical needs.
  • URL: https://www.protagonist-inc.com
  • Investor Relations URL: https://investors.protagonist-inc.com/
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Mar. 10, 2022
  • Last Earnings Release: Nov. 03, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
FBTCX Fidelity Advisor® Biotechnology C 0.96%
IWC iShares Micro-Cap ETF 0.29%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.